FAVARETTO, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 2.292
AS - Asia 352
EU - Europa 338
OC - Oceania 4
SA - Sud America 4
Totale 2.990
Nazione #
US - Stati Uniti d'America 2.288
CN - Cina 200
IT - Italia 134
SG - Singapore 119
FI - Finlandia 46
DE - Germania 38
SE - Svezia 32
FR - Francia 26
GB - Regno Unito 25
VN - Vietnam 15
UA - Ucraina 12
IN - India 8
IE - Irlanda 7
KR - Corea 5
AT - Austria 4
CA - Canada 4
AR - Argentina 3
BE - Belgio 3
NL - Olanda 3
AU - Australia 2
CZ - Repubblica Ceca 2
NZ - Nuova Zelanda 2
RU - Federazione Russa 2
EC - Ecuador 1
GR - Grecia 1
HK - Hong Kong 1
IL - Israele 1
JO - Giordania 1
JP - Giappone 1
LT - Lituania 1
LU - Lussemburgo 1
RO - Romania 1
TR - Turchia 1
Totale 2.990
Città #
Fairfield 375
Woodbridge 255
Chandler 252
Ashburn 174
Cambridge 150
Houston 145
Seattle 137
Wilmington 112
Singapore 97
Ann Arbor 93
Padova 51
Boardman 49
Beijing 45
Princeton 42
Jacksonville 38
Helsinki 35
Medford 31
Santa Clara 27
Des Moines 24
San Diego 24
Nanjing 23
Dong Ket 15
Guangzhou 14
New York 13
Roxbury 13
Redwood City 9
Cagliari 8
Falls Church 8
Changsha 7
Dublin 7
Jinan 7
London 7
Nanchang 7
Redmond 7
Shenyang 7
Hebei 6
Los Angeles 6
Frankfurt am Main 5
Milan 5
Pune 5
Naples 4
Tianjin 4
Washington 4
Brendola 3
Bupyeong-gu 3
Cordoba 3
Faenza 3
Kharkiv 3
Lebanon 3
Ningbo 3
Parma 3
Vienna 3
Arco 2
Borås 2
Campodarsego 2
Dallas 2
Dalmine 2
Fort Worth 2
Fuzhou 2
Groningen 2
Haikou 2
Hangzhou 2
Hanover 2
Hefei 2
Jiaxing 2
Kilburn 2
Lanzhou 2
Menlo Park 2
Ogden 2
Paris 2
Philadelphia 2
Racale 2
Rome 2
San Francisco 2
San Pancrazio Salentino 2
Schaarbeek 2
Sherman Oaks 2
Sydney 2
Taiyuan 2
Taizhou 2
Toronto 2
Treviso 2
Vicenza 2
Vigevano 2
Vignola 2
Amman 1
Amsterdam 1
Auckland 1
Bologna 1
Brescia 1
Brno 1
Brussels 1
Cernusco sul Naviglio 1
Chicago 1
Chiswick 1
Christchurch 1
Cormeilles-en-Parisis 1
Council Bluffs 1
Dongguan 1
Edinburgh 1
Totale 2.455
Nome #
CK2 modulates adipocyte insulin-signaling and is up-regulated in human obesity 202
SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy 179
Microarray analysis during adipogenesis identifies new genes altered by antiretroviral drugs 146
Characterization of subcutaneous and omental adipose tissue in patients with obesity and with different degrees of glucose impairment 144
Protein kinase CK2 is involved in adipose tissue insulin signaling and remodeling during obesity and weight loss 141
Increased mitochondrial calcium uniporter in adipocytes underlies mitochondrial alterations associated with insulin resistance. 130
In vitro comparative assessment of decellularized bovine pericardial patches and commercial bioprosthetic heart valves 114
ALMS1-Deficient Fibroblasts Over-Express Extra-Cellular Matrix Components, Display Cell Cycle Delay and Are Resistant to Apoptosis. 108
Alström syndrome is associated with short stature and reduced GH reserve. 108
GLUT4 defects in adipose tissue are early signs of metabolic alterations in alms1GT/GT, a mouse model for obesity and insulin resistance 105
The progression from obesity to type 2 diabetes in Alström syndrome. 102
Resting Energy Expenditure, Insulin Resistance and UCP1 Expression in Human Subcutaneous and Visceral Adipose Tissue of Patients With Obesity 93
Adipogenic potential of skeletal muscle satellite cells 92
Alström syndrome is associated with short stature and reduced GH reserve 90
Effects of interferon alpha on human hepatoma cell lines: DNA microarrays analysis and evaluation of cell proliferation 84
Obesità, insulino resistenza e nuove molecole segnale: studi nell'uomo e in modelli animali 82
In silico prediction of blood cholesterol levels from genotype data 79
Cell biology aspects of alstrom syndrome, a monogenic model of metabolic syndrome 76
Regulation of Alstrom syndrome gene expression during adipogenesis and its relationship with fat cell insulin sensitivity 75
White adipose tissue expansion in multiple symmetric lipomatosis is associated with upregulation of ck2, akt and erk1/2 71
Rhabdomyosarcoma Cells Produce Their Own Extracellular Matrix With Minimal Involvement of Cancer-Associated Fibroblasts: A Preliminary Study 71
Neurocognitive assessment and DNA sequencing expand the phenotype and genotype spectrum of Alström syndrome 67
"Exploring the role of growth hormone antagonist on adipocytes" 65
Alström Syndrome: Mutation Spectrum of ALMS1 65
"UCP1 mRNA expression in human subcutaneous and visceral adipose tissue during the progression from obesity to diabetes" 60
Association of obstructive sleep apnea with non-alcoholic fatty liver disease in patients with obesity: an observational study 52
Monogenic diabetes syndromes: Locus-specific databases for Alström, Wolfram, and Thiamine-responsive megaloblastic anemia 49
In vitro chronic glycation induces AGEs accumulation reducing insulin stimulated glucose uptake and increasing GLP1R in adipocytes 48
Liver Fibrosis and Steatosis in Alstrom Syndrome: A Genetic Model for Metabolic Syndrome 46
Consensus clinical management guidelines for Alström syndrome 45
The mitochondrial protein Opa1 promotes adipocyte browning that is dependent on urea cycle metabolites 41
Molecular and Pharmacological Evidence for the Expression of Multiple Functional P2 Purinergic Receptors in Human Adipocytes 41
Expression of P2 purinergic receptors in human adipocytes 40
Adipogenic progenitors in different organs: Pathophysiological implications 40
Alström syndrome: an ultra-rare monogenic disorder as a model for insulin resistance, type 2 diabetes mellitus and obesity 32
ASCs and their role in obesity and metabolic diseases 32
Metabolic slowing vanished 5 years after sleeve gastrectomy in patients with obesity and prediabetes/diabetes 21
Totale 3.036
Categoria #
all - tutte 12.494
article - articoli 11.524
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.018


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020376 0 0 0 0 44 33 53 48 51 88 44 15
2020/2021545 19 40 41 23 27 21 34 33 53 107 75 72
2021/2022512 12 44 39 42 41 44 27 36 56 27 31 113
2022/2023510 91 60 11 63 71 62 6 31 72 2 29 12
2023/2024288 12 46 39 20 33 33 18 20 9 13 26 19
2024/2025283 5 93 42 65 78 0 0 0 0 0 0 0
Totale 3.036